Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ANGO · against 451 other Healthcare companies of similar size
Ranked #329 of 452 · scores higher than 26% of peers
Bars: peers in each 10-point band of the profitability score52 peers with a profitability score of 20–29, including ANGO · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | ANGO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 422 reported | -22.2% | 1.9% | 22% | 33% | |
| Operating marginHigher is better · 423 reported | -11.2% | 4.8% | 27% | 33% | |
| Return on assetsHigher is better · 449 reported | -13.6% | 0.9% | 24% | 33% | |
| Return on equityHigher is better · 428 reported | -20.8% | 0.9% | 28% | Context only | |
| Gross marginHigher is better · 468 reported | 54.6% | 40.0% | 66% | Context only |
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 914M USD | 99 | 81 | |
| 1 | 609M USD | 99 | 91 | |
| 325 | 4.0B CNY (≈$563M) | 26 | 18 | |
| 325 | 467M USD | 26 | 44 | |
| 329 | 4.6B CNY (≈$645M) | 25 | 17 | |
| 329 | 3.5B CNY (≈$487M) | 25 | 25 | |
| 329 | 493M USD | 25 | 38 | |
| 329 | 533M USD | 25 | 36 | |
| 329 | 578M USD | 25 | 22 | |
| 329 | 660M GBP (≈$858M) | 25 | 35 | |
| 335 | 3.1B CNY (≈$438M) | 24 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score